Yearly GDP, HIPC and HEPC per capita (All in current MYR). by Ridzuan Kunji Koya (20234865)

Subjects:

Change In affordability with various measures of income and consumption estimates. by Ridzuan Kunji Koya (20234865)

Subjects:

Affordability calculation using actual consumption estimates (ConsumptionRIP). by Ridzuan Kunji Koya (20234865)

Subjects:

Affordability calculation using conventional method (2000RIP). by Ridzuan Kunji Koya (20234865)

Subjects:

RIP in urban areas. by Ridzuan Kunji Koya (20234865)

Subjects:

RIP in rural areas. by Ridzuan Kunji Koya (20234865)

Subjects:

Raw data file. by Ridzuan Kunji Koya (20234865)

Subjects:

Nomenclature of the different versions of the RIP. by Ridzuan Kunji Koya (20234865)

Subjects:

The global numbers of prevalent cases (A), incident cases (B), deaths (C), DALYs (D), and corresponding rates of chronic obstructive pulmonary disease per 100,000 population in old... by Kaifang Meng (13848535)

Subjects:

Larger example of stimuli with cue relevant for Task 3. by Marcel F. Hinss (14675457)

Crosstalk models to describe DEM-induced DDR activity. by Elsje J. Burgers (20903422)

Subjects:

Crosstalk models to describe etoposide-induced OSR activity. by Elsje J. Burgers (20903422)

Subjects:

DDR model describes data from HepG2 cells exposed to etoposide. by Elsje J. Burgers (20903422)

Subjects:

OSR model describes data from HepG2 cells exposed to DEM when NRF2 stimulates KEAP1 production. by Elsje J. Burgers (20903422)

Subjects:

<i>In silico</i> knockdown predictions on the basis of crosstalk models. by Elsje J. Burgers (20903422)

Subjects:

Comparison of social determinants of health (SDH) between hot and cold spots. Except for sewerage coverage and physician density, medians and interquartile ranges are presented. Ab... by Andrés Fernando Vinueza-Veloz (21681409)

Subjects:

Biases in larger populations. by Sander W. Keemink (21253563)

“…With amplitude scaling the mean population activity was kept the same by scaling down the response amplitude for larger population (blue curve). …”

The comparison of GCF visfatin level before and three months after NSPT among cases with periodontitis. by Zahra Tajik (20752452)

The comparison of saliva visfatin level before and three months after NSPT among cases with periodontitis. by Zahra Tajik (20752452)

Summary of meta-analysis results to compare visfatin level before and after NSPT among cases with periodontitis. by Zahra Tajik (20752452)